The answer is both. And knowing which is which could save you a significant amount of money. Regenerative aesthetics is the fastest growing category in aesthetic medicine right now. Exosomes. PRP. Polynucleotides. Biostimulators. Growth factors. The language is sophisticated, the pricing is significant and the marketing is extraordinary. Every conference, every clinic, every aesthetics influencer is talking about it. And underneath all of that noise — there is real science. There is also real opportunism.
What Regenerative Aesthetics Actually Means
The concept is genuinely compelling. Rather than adding something foreign to the face — a filler, a toxin — regenerative treatments work by stimulating the body's own repair mechanisms. Signaling cells to produce new collagen and elastin, supporting the skin's structural renewal from within. For women who have watched fillers trend toward dissolution — nearly half of those who have had dermal filler have at some point had their treatment dissolved — the appeal of something that works with the body is completely understandable.
What the Evidence Actually Shows
Let me be specific. PRP — platelet rich plasma — is backed by a substantial body of peer-reviewed evidence. Multiple randomized controlled trials and meta-analyses have demonstrated statistically significant improvements in skin quality, hair density and scar appearance. The science is real and the results are documented.
Polynucleotides also carry a growing body of peer-reviewed evidence and a clearer regulatory standing — well-understood mechanism, strong safety profile and increasing clinical data. They have real research behind them.
And then there are exosomes. Pay very close attention here. No FDA-approved exosome products currently exist for aesthetic use. Early research has found promising associations, but multiple reviews have concluded that larger, standardized clinical trials are still needed. Long-term safety data is still limited.
Even at international aesthetic medicine conferences, there have been frank discussions about the controversies and regulatory uncertainties that still surround exosome therapy. Sourcing, processing consistency and quality control remain legitimate concerns. Exosomes are being sold to you aggressively before the science has fully caught up with the price tag.
The Snake Oil Problem — Again
The snake oil salesmen in the aesthetics space are not going anywhere. The way to navigate it is to ask the right questions before you spend a single dollar. What is the evidence base for this specific treatment? What clinical trials exist? What do they show? And — most importantly — what is the person recommending it going to earn when you say yes? That last question changes the conversation every single time.
Inside The Regan House™, the experts in my community have these conversations in real time — about what the evidence actually supports. The scientific evidence for regenerative aesthetics in 2026 varies significantly by modality — ranging from moderate quality clinical trial data for PRP to predominantly preclinical evidence for exosomes and many stem cell therapies. You deserve to know which is which before you open your wallet.